Patents Represented by Attorney, Agent or Law Firm Monte Browder
  • Isoxazolo [4,5-d] pyrimidines as CRF antagonists
    Patent number: 6589958
    Abstract: The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula: wherein R is an aromatic or heteroaromatic ring, or pharmaceutically acceptable salt form thereof, which are useful as CRF antagonists.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: July 8, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventor: William Eric Frietze
  • Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
    Patent number: 6579876
    Abstract: The present invention describes novel compounds of formula (Ib): wherein D is aryl or heteroaryl or pharmaceutically acceptable salt forms thereof, which are useful as corticotropin releasing factor antagonists.
    Type: Grant
    Filed: February 11, 2002
    Date of Patent: June 17, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Paul Joseph Gilligan, Richard Eric Olson, William Eric Frietze